Funds support local vaccine-making

Vietnam and other countries are in line to get their own vaccine manufacturing capabilities, thanks to PATH, the Program for Appropriate Technology in Health. The international nonprofit is receiving $8 million from HHS's Biomedical Advanced Research and Development Authority to assist in the production and clinical development of influenza vaccines, a step toward building local production capacity in developing countries. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.